• Home
  • About us
  • Log-In
  • Join Us
  • Sitemap
  • Recruit
제품/실험 Q&A
클레임 접수
기기 A/S 접수
클레임 진행조회
 제품안내  분석 제작 서비스   신약개발 탐색 서비스

Drug transporter inhibition assays

Lead compounds에 대한 Transporter inhibition activity를 측정해드립니다.

Eurofins Discovery
제품 문의하기

  • 신약의 FDA와 EMA 승인을 위해 권장되는 시험입니다.
  • Single 농도 (10 μM) 혹은 8개 농도(0.03, 0.1, 0.3, 1, 3, 10, 30, 100 μM)에서 테스트 하여 IC50 값과 그래프를 제공합니다.
  • test 가능한 transporter : ABC transporters (MDR1/P-gp, BCRP), SLC transporters (OAT1, OAT3, OATP1B3, OCT2)
  • 위의 transporter에서 결과가 좋을 경우, 다른 transporter를 이용한 실험도 가능합니다.
  • 결과의 재현성을 위해 recombinant cell line을 사용합니다.
  • 소요 기간 : 샘플 회수 후, 약 3주
  • 필요 샘플 양 : 100 μl (10 mM in DMSO) or 2mg (solid stock)
  • 실험 방법
    • Cells are seeded in a 96-well culture plate typically at 20,000 cells/well and are used on days 2 or 3 post-seeding. On the day of assay the test compound is prepared in assay buffer (HBSS-HEPES, pH 7.4), added to the cell plate, and preincubated at 37 ℃ for 15 min.
    • Subsequently substrate is added to the plate followed by 20-min incubation at 37 ℃.The plate is then washed with cold assay buffer followed by fluorescence reading for assays with fluorogenic substrates.
    • For assays with radioactive substrates the cells are lysed using NaOH solution (0.2 N) followed by liquid scintillation counting.

Ref. No. Transporter  Cell line  Substrate  Reference inhibitor
1324 P-gp  MDR1-MDCKII  Calcein AM  Verapamil
3633 BCRP  BCRP-CHO  Hoechst 33342  KO143
3878 MRP1  MRP1-HEK  Calcein AM  MK571
3879 MRP2  MRP2-HEK  CDCF  MK571
3880 MRP3  MRP3-HEK  CDCF  MK571
3660 OATP1B1  OATP1B1-CHO  Fluorescein methotrexate  Rifampicin
3661 OATP1B3  OATP1B3-CHO  Fluorescein methotrexate  Rifampicin
3658 OAT1  OAT1-CHO  6-carboxyfluorescein  Probenecid
3659 OAT3  OAT3-CHO  6-carboxyfluorescein  Probenecid
3746 OCT1 OCT1-CHO  ASP+  Verapamil
3726 OCT2 OCT2-CHO  ASP+  Verapamil
3656 ASBT  ASBT-CHO  3H-taurocholic acid  Glycochenodeoxycholate
3657 NTCP  NTCP-CHO  3H-taurocholic acid  Cyclosporin A

Inhibition profiles of FDA and EMA recommended transporters
Inhibition of transport of fluorogenic substrates by transporter inhibitor reference compounds (% of control response)